Skip to content
Disclosery

EXANE DERIVATIVES: SMPL position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on SMPL, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 20 SMPL shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 20 shares
    Change vs previous 13F -13,221 shares

    <0.01% of the 13F portfolio, value $755.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 13,241 shares
    Change vs previous 13F -3,682 shares

    0.14% of the 13F portfolio, value $502,465.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 16,923 shares
    Change vs previous 13F -1,745 shares

    0.17% of the 13F portfolio, value $703,464.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 18,668 shares
    Change vs previous 13F +10,018 shares

    0.16% of the 13F portfolio, value $643,836.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 8,650 shares
    Change vs previous 13F -2,725 shares

    0.07% of the 13F portfolio, value $318,226.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 11,375 shares
    Change vs previous 13F -4,829 shares

    0.1% of the 13F portfolio, value $346,012.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 16,204 shares
    Change vs previous 13F not available

    0.15% of the 13F portfolio, value $508,134.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).